Geron Corp. (GERN)

NASDAQ

$1,23

$--

(0,00%)

Pre-Market

Geron Corp. (GERN) Live Price Chart

Last updated: ⁦2026-10-13 09:31:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Geron Corp. (GERN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1,23, with a market capitalisation of $787,03M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,04 to $2,01. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$787,03M
Open	$1,23
Day's High	$16,80
Day's Low	$0,75
Previous Close	$1,22
Volume	1,06K
Average Volume	9,92M
P/E Ratio	--
52-Week High	$2,01
52-Week Low	$1,04
Dividend Yield	--
Earnings Date	--

Geron Corp. (GERN) Pre-Market Stock Price

Geron Corp. (GERN) is trading at $1,23 in pre-market trading as of 2026-10-13 08:31:00, up 0,41% ($0,01) from the previous close of $1,22

Pre-market trading shows how investors are pricing GERN before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Geron Corp. (GERN) 7-Day Stock Price Change

Over the past seven days, Geron Corp. (GERN) moved from $1,20 to $1,23, representing a gain of 2,08% ($0,03).

The stock traded between $1,17 and $1,26 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 7,39 million shares, down versus the previous seven-day period, indicating lower trading activity.

GERN 52-Week Price Position

Position in Range: 19,1%

52W Low$1,04

52W High$2,01

GERN is currently trading at $1,23, placing it 19,1% of the way from its 52-week low of $1,04 to its 52-week high of $2,01. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Geron Corp. (GERN)?

Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.

Geron Corp. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	258
Exchange	NASDAQ
Company Website	https://www.geron.com

How to Buy Geron Corp. (GERN) Stock on MEXC

Eligible investors can buy real shares of Geron Corp. (GERN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GERN and Place Your Order

Open the RealStocks trading page and search for GERN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Geron Corp. (GERN) stock price today?

Geron Corp. (GERN) is currently trading at $ 1,23, up 0,41% ($0,01) from the previous close of $ 1,22. Intraday prices update in real time during regular trading hours.

2.Is GERN stock going up or down today?

As of 2026-10-13 08:31:00, GERN is trading at $ 1,23, up 0,41% ($0,01) from its previous close of $ 1,22. The stock has traded between $ 0,75 and $ 16,80 during today’s regular session. Past price movements do not guarantee future results.

3.What is GERN pre-market price?

As of 2026-10-13 08:31:00, GERN is trading at $ 1,23 in pre-market trading, up 0,41% ($0,01) from the previous close of $ 1,22. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GERN after-hours price?

As of 2026-10-13 08:31:00, GERN is trading at $ 1,23 in after-hours trading, up 0,41% ($0,01) from the regular-session close of $ 1,22. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GERN stock trading now?

GERN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GERN sit relative to its 52-week high and low?

Over the past 52 weeks, GERN has traded between a low of $ 1,04 and a high of $ 2,01. At $ 1,23, the stock is positioned 19,1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Geron Corp. in?

Geron Corp. (GERN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Geron Corp.'s market capitalisation and where is it listed?

Geron Corp. is listed on the NASDAQ exchange with a market capitalisation of $ 787,03M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GERN valued in terms of P/E ratio and EPS?

GERN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0,11. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Geron Corp. pay a dividend?

Geron Corp. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.